Thromboembolic events associated with combined oral contraceptives: a real-world study based on the FDA adverse event reporting system (FAERS) database
This study found an increased risk of TEEs treated with COCs, particularly with drospirenone. We should pay close attention to risk monitor on the treatment of early stages.
Authors
- Yanhong Liu (ORCID: https://orcid.org/0000-0001-6838-7318)
- Rong Feng
- Guixin Zhao (ORCID: https://orcid.org/0000-0002-0508-2514)
Institutions
- Kunming Third People's Hospital (CN)
- Yunnan Maternal and Child Health (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1080/14740338.2024.2438755
- Primary Topic
- Reproductive Health and Contraception
- Type
- article
- Field-Weighted Citation Impact
- 0.00